세계의 유방 고정술 시장 평가 : 제품별, 기법별, 최종사용자별, 지역별 - 기회 및 예측(2018-2032년)

Global mastopexy market is projected to witness a CAGR of 6.13% during the forecast period 2025-2032, growing from USD 2.52 billion in 2024 to USD 4.05 billion in 2032. The global market for mastopexy is experiencing substantial growth as more people seek aesthetic treatments for body contouring and the treatment of aging symptoms. A breast lift operation called mastopexy serves to elevate and reshape drooping breasts, which results from natural aging, pregnancy, breastfeeding, and significant weight loss. Social media influence, alongside changing beauty standards, drives increasing numbers of people, particularly women between 30 to 50 years old, to select breast lift surgeries.

The market receives positive effects from surgical technique improvement, which include minimally invasive procedures alongside advanced implant technologies and faster recovery periods that improve safety and results. The market holds its position in North America because of substantial healthcare expenditures and numerous skilled cosmetic surgeons, together with a high number of annual procedures. The Asia-Pacific region will lead market expansion at the fastest rate because medical tourism grows alongside rising disposable income and improved access to aesthetic healthcare facilities.

The popularity of combination procedures, including mastopexy with augmentation, together with customized solution availability, helps the market reach additional patients. The mastopexy market shows strong potential for continued expansion throughout the upcoming years because of these market drivers.

For instance, in February 2025, Establishment Labs Holdings Inc. operates as a worldwide medical technology company that focuses on enhancing women's health and wellness through breast aesthetics and reconstruction procedures. The company officially introduced Preserve in Brazil, which marks the initial phase of its worldwide product expansion. The Company introduced its second product through the minimally invasive platform named Preserve, which continues the development of Mia Femtech by Establishment Labs.

Aesthetic and Anti-aging Trends Boost Global Mastopexy Market Demand

The global demand for mastopexy procedures experiences substantial growth because of aesthetic and anti-aging trends. The growing societal interest in youthful appearance, together with body image concerns, leads many individuals, primarily females, to undergo cosmetic surgery for physical aesthetic improvements. Breast lift surgery or mastopexy provides treatment for drooping breasts which occur from aging, weight fluctuations, and pregnancy effects, to restore youthful breast contours. Social media platforms joined with celebrity culture and beauty influences have normalized cosmetic procedures, which have increased public knowledge and acceptance. Growing aging population with rising disposable income chooses to spend money on procedures that eliminate visible aging signs. Mastopexy has become more attractive to potential patients because of the changing patient demographics and improved surgical methods, which require fewer incisions and shorter healing periods. The marketing approach from clinics positions these procedures within anti-aging packages to drive higher patient interest. Mastopexy procedures continue to experience steady growth because of current aesthetic trends and anti-aging developments.

Additionally, to maintain the trend, companies are collaborating despite advancements in breast cancer research and treatment. For instance, in October 2024, Galderma confirmed its ongoing partnership with the National Breast Cancer Foundation (NBCF) to support breast cancer survivors. The partnership continues its work to support individuals affected by breast cancer by providing services that enable survival and thriving. The partnership works to provide cutting-edge aesthetic solutions that enable individuals to rebuild their confidence and experience life with fresh energy.

Advancements in Surgical Techniques Fuel Market Growth

The mastopexy market benefits from surgical technique innovations, which drive its growth through better results alongside lower risk factors, and enhanced patient satisfaction. The current mastopexy operations rely on minimal surgical techniques alongside better incision designs and enhanced suturing systems to produce natural results which decrease scar visibility. Patients show rising interest in three main mastopexy market developments, which include laser-assisted lifts and 3D imaging pre-surgical planning, as well as combination procedures with mastopexy and augmentation. Internal bra techniques together with absorbable mesh implants offer extended duration of results, which minimizes the requirement for revision surgeries. The latest developments in mastopexy procedures have shortened recovery durations and reduced medical complications while improving operational effectiveness, which draws more patients and surgeons to choose this procedure. Clinics and manufacturers direct their investments toward new technologies because aesthetic standards continue to evolve while patients seek customized, safe effective procedures. These advancements serve as essential drivers for the rapid global expansion of the mastopexy market.

For instance, in September 2024, POLYTECH Health & Aesthetics GmbH introduced Opticon Plus as its newest product in its extensive product range. The new implant from POLYTECH extends their comprehensive product line by bridging the space between Replicon and Opticon anatomical forms. Surgeons now have access to Opticon Plus, which provides a base design that stands between the round Replicon base and the standard Opticon short oval base.

Breast Implants Hold the Largest Global Mastopexy Market Share

Breast implants maintain the highest market share within the mastopexy industry because patients increasingly choose dual procedures that address volume enhancement and breast position improvement. Patients who select breast lifts simultaneously pursue enhanced breast volume and youthful contours which implants deliver successfully. The combination of mastopexy with augmentation has gained popularity because it provides enduring aesthetic results that attract women who experience volume loss from aging and pregnancy and weight loss. The development of safer materials and diverse implant shapes and sizes, alongside more realistic outcomes, has boosted consumer confidence about implant technology. Plastic surgeons recommend implants during mastopexy procedures to achieve better symmetry and firmness which leads to more patients choosing this option. Beauty standards and customizable implant options together drive the preference for breast implants which maintain their position as the leading choice in the global mastopexy market.

For instance, in December 2024, Mentor Worldwide LLC, a part of Johnson & Johnson MedTech, revealed that the U.S. Food and Drug Administration (FDA) approved MENTOR MemoryGel Enhance Breast Implants for use in both primary and revision post-mastectomy breast reconstruction operations. The innovative silicone gel-filled implant collection provides an expanded selection of base widths together with new projections and volumes that extend to 930 cc through 1445 cc, the highest volume available in the market. The commercial debut of MemoryGel Enhance Breast Implants by Mentor occurs in the United States starting from mid-2025.

North America Dominates the Global Mastopexy Market Size

North America dominates the global mastopexy market due to several key factors such as high healthcare budgets, modern medical facilities, and a developed, strong public interest in cosmetic treatments. Aesthetic surgery rates in the United States rank among the highest worldwide because many women select mastopexy for breast sagging repair, which results from aging and weight changes and pregnancy effects. Market expansion receives significant support from the availability of skilled plastic surgeons and advanced surgical technologies, together with widespread public knowledge about aesthetic procedures. The market is expanding because of increasing disposable income levels and growing cultural support for cosmetic procedures. The region also gains from powerful social media trends and celebrity-driven beauty standards that motivate more people to pursue body contouring treatments. The rising focus on personal wellness and self-care practices has integrated mastopexy into broader anti-aging and lifestyle enhancement trends, which makes North America the leading market for this procedure.

Additionally, the rising cases of breast cancer support this region to grow in the mastopexy market. For instance, according to the American Cancer Society's estimates, about 316,950 new cases of invasive breast cancer will be diagnosed in women in 2025. Such growing cases increase the demand for mastopexy or breast lift surgery.

Impact of U.S. Tariffs on Global Mastopexy Market

U.S. tariffs have triggered substantial market shifts in mastopexy (breast lift) procedures because imported medical devices and materials have become more expensive. Surgical equipment, along with implants and related supplies, faces increased tariffs, which drive up prices for medical facilities and their patients, potentially leading to decreased demand. The rising costs might cause healthcare providers to explore domestic supply options or postpone non-urgent operations, thus affecting market growth rates. The increased expenses discourage businesses from launching operations in the aesthetic surgery market, which results in reduced innovation and fewer available services. The rising costs serve as a deterrent for patients who might otherwise undergo mastopexy treatments, which results in reduced procedure numbers. Domestic manufacturers experience an increased market share because consumers prefer local manufacturing products over imported materials. U.S. tariffs have generated financial uncertainties that affect pricing structures, as well as accessibility and market operations within the mastopexy industry.

Key Players Landscape and Outlook

The global mastopexy market competition involves major aesthetic corporations and clinical facilities that specialize in innovation alongside patient safety measures and satisfaction protocols. Main players direct their investments toward enhanced surgical procedures and implant technology alongside strategic alliances to broaden their worldwide presence. The market outlook remains optimistic because of increasing cosmetic treatment popularity, together with expanding medical tourism and shifting notions of beauty. The market will show consistent expansion while facing stronger competition due to ongoing technological progress throughout the next years.

In June 2023, the U.S. Food and Drug Administration (FDA) provided 510(k) clearance to Sientra, Inc. for its innovative AlloX2 Pro Tissue Expander. The AlloX2 Pro became the initial tissue expander in the United States to receive MRI-conditional approval, which permits its use during magnetic resonance imaging procedures needed by breast reconstruction patients.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Impact of U.S. Tariffs

4. Executive Summary

5. Global Mastopexy Market Outlook, 2018-2032F

• 5.1. Market Size Analysis & Forecast
  • 5.1.1. By Value
• 5.2. Market Share Analysis & Forecast
  • 5.2.1. By Product
    • 5.2.1.1. Breast Implants
      • 5.2.1.1.1. Silicone Implants
      • 5.2.1.1.2. Saline Implants
      • 5.2.1.1.3. Cohesive Gel Implants
    • 5.2.1.2. Surgical Instruments
    • 5.2.1.3. Energy-based Devices
      • 5.2.1.3.1. Radiofrequency (RF) Devices
      • 5.2.1.3.2. High-Intensity Focused Ultrasound (HIFU)
      • 5.2.1.3.3. Laser-based Skin Tightening Equipment
    • 5.2.1.4. Others
  • 5.2.2. By Technique
    • 5.2.2.1. Anchor Mastopexy
    • 5.2.2.2. Crescent Mastopexy
    • 5.2.2.3. Vertical Mastopexy
    • 5.2.2.4. Others
  • 5.2.3. By End-user
    • 5.2.3.1. Hospitals
    • 5.2.3.2. Aesthetic and Cosmetology Clinics
    • 5.2.3.3. Others
  • 5.2.4. By Region
    • 5.2.4.1. North America
    • 5.2.4.2. Europe
    • 5.2.4.3. Asia-Pacific
    • 5.2.4.4. South America
    • 5.2.4.5. Middle East and Africa
  • 5.2.5. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2024)
• 5.3. Market Map Analysis, 2024
  • 5.3.1. By Product
  • 5.3.2. By Technique
  • 5.3.3. By End-user
  • 5.3.4. By Region

6. North America Mastopexy Market Outlook, 2018-2032F

• 6.1. Market Size Analysis & Forecast
  • 6.1.1. By Value
• 6.2. Market Share Analysis & Forecast
  • 6.2.1. By Product
    • 6.2.1.1. Breast Implants
      • 6.2.1.1.1. Silicone Implants
      • 6.2.1.1.2. Saline Implants
      • 6.2.1.1.3. Cohesive Gel Implants
    • 6.2.1.2. Surgical Instruments
    • 6.2.1.3. Energy-based Devices
      • 6.2.1.3.1. Radiofrequency (RF) Devices
      • 6.2.1.3.2. High-Intensity Focused Ultrasound (HIFU)
      • 6.2.1.3.3. Laser-based Skin Tightening Equipment
    • 6.2.1.4. Others
  • 6.2.2. By Technique
    • 6.2.2.1. Anchor Mastopexy
    • 6.2.2.2. Crescent Mastopexy
    • 6.2.2.3. Vertical Mastopexy
    • 6.2.2.4. Others
  • 6.2.3. By End-user
    • 6.2.3.1. Hospitals
    • 6.2.3.2. Aesthetic and Cosmetology Clinics
    • 6.2.3.3. Others
  • 6.2.4. By Country Share
    • 6.2.4.1. United States
    • 6.2.4.2. Canada
    • 6.2.4.3. Mexico
• 6.3. Country Market Assessment
  • 6.3.1. United States Mastopexy Market Outlook, 2018-2032F*
    • 6.3.1.1. Market Size Analysis & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share Analysis & Forecast
      • 6.3.1.2.1. By Product
        • 6.3.1.2.1.1. Breast Implants
        • 6.3.1.2.1.1.1. Silicone Implants
        • 6.3.1.2.1.1.2. Saline Implants
        • 6.3.1.2.1.1.3. Cohesive Gel Implants
        • 6.3.1.2.1.2. Surgical Instruments
        • 6.3.1.2.1.3. Energy-based Devices
        • 6.3.1.2.1.3.1. Radiofrequency (RF) Devices
        • 6.3.1.2.1.3.2. High-Intensity Focused Ultrasound (HIFU)
        • 6.3.1.2.1.3.3. Laser-based Skin Tightening Equipment
        • 6.3.1.2.1.4. Others
      • 6.3.1.2.2. By Technique
        • 6.3.1.2.2.1. Anchor Mastopexy
        • 6.3.1.2.2.2. Crescent Mastopexy
        • 6.3.1.2.2.3. Vertical Mastopexy
        • 6.3.1.2.2.4. Others
      • 6.3.1.2.3. By End-user
        • 6.3.1.2.3.1. Hospitals
        • 6.3.1.2.3.2. Aesthetic and Cosmetology Clinics
        • 6.3.1.2.3.3. Others
  • 6.3.2. Canada
  • 6.3.3. Mexico

All segments will be provided for all regions and countries covered

7. Europe Mastopexy Market Outlook, 2018-2032F

• 7.1. Germany
• 7.2. France
• 7.3. Italy
• 7.4. United Kingdom
• 7.5. Russia
• 7.6. Netherlands
• 7.7. Spain
• 7.8. Turkey
• 7.9. Poland

8. Asia-Pacific Mastopexy Market Outlook, 2018-2032F

• 8.1. India
• 8.2. China
• 8.3. Japan
• 8.4. Australia
• 8.5. Vietnam
• 8.6. South Korea
• 8.7. Indonesia
• 8.8. Philippines

9. South America Mastopexy Market Outlook, 2018-2032F

• 9.1. Brazil
• 9.2. Argentina

10. Middle East and Africa Mastopexy Market Outlook, 2018-2032F

• 10.1. Saudi Arabia
• 10.2. UAE
• 10.3. South Africa

11. Demand Supply Analysis

12. Porter's Five Forces Analysis

13. PESTLE Analysis

14. Pricing Analysis

15. Market Dynamics

• 15.1. Market Drivers
• 15.2. Market Challenges

16. Market Trends and Developments

17. Policy and Regulatory Landscape

18. Case Studies

19. Competitive Landscape

• 19.1. Competition Matrix of Top 5 Market Leaders
• 19.2. SWOT Analysis for Top 5 Players
• 19.3. Key Players Landscape for Top 10 Market Players
  • 19.3.1. Allergan Plc (Abbvie Inc.)
    • 19.3.1.1. Company Details
    • 19.3.1.2. Key Management Personnel
    • 19.3.1.3. Products and Services
    • 19.3.1.4. Financials (As Reported)
    • 19.3.1.5. Key Market Focus and Geographical Presence
    • 19.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
  • 19.3.2. GC Aesthetics Plc
  • 19.3.3. Mentor Worldwide LLC (Johnson & Johnson)
  • 19.3.4. Groupe Sebbin SAS
  • 19.3.5. Sientra Inc.
  • 19.3.6. Establishment Labs S.A.
  • 19.3.7. Shanghai Kangning Medical Supplies Ltd.
  • 19.3.8. Polytech Health & Aesthetics GmbH
  • 19.3.9. HansBiomed Co. Ltd.
  • 19.3.10. Silimed Industria de Implantes LTDA

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

20. Strategic Recommendations

21. About Us and Disclaimer